KREBS BIOCHEMICALS & INDUSTRIES
Back to Cashflow Statement
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹5.56 Cr | ₹37 Cr | ₹40 Cr | ₹38 Cr | ₹29 Cr |
What is the latest Cash Flow from Financing Activities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹5.56 Cr |
Mar2023 | ₹37 Cr |
Mar2022 | ₹40 Cr |
Mar2021 | ₹38 Cr |
Mar2020 | ₹29 Cr |
How is Cash Flow from Financing Activities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹5.56 Cr | -85.10 | |
Mar2023 | ₹37 Cr | -5.48 | |
Mar2022 | ₹40 Cr | 4.90 | |
Mar2021 | ₹38 Cr | 31.80 | |
Mar2020 | ₹29 Cr | - |
Compare Cash Flow from Financing Activities of peers of KREBS BIOCHEMICALS & INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KREBS BIOCHEMICALS & INDUSTRIES | ₹166.3 Cr | 2.3% | -11.8% | -9.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,306.0 Cr | -6% | -7.3% | -12% | Stock Analytics |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KREBS BIOCHEMICALS & INDUSTRIES | 2.3% |
-11.8% |
-9.8% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses